NL-OMON50965已完成不适用
Randomized Two Arm Multi-Center Study to Evaluate the Safety and Efficacy of the Use of Magentiq Eye's Automatic Polyp Detection System (ME-APDS) During Colonoscopy - Magentiq Eye Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Able to provide written informed consent prior to any study procedures;
- •2. Able to communicate clearly with the Investigators and study staff;
- •3. Males and females aged between 18 * 90 years of age;
- •4. Referred and Scheduled for either screening or surveillance colonoscopy
- •which is sched-uled every 3 to 10 years;
- •5. Has not been referred to the test after positive iFOBT.
排除标准
- •1. Has a known or suspected colorectal tumor or polyp on referral;
- •2. Has a referral for therapeutic procedure (i.e. endoscopic mucosal resection,
- •intervention to stop a lower gastro-intestinal bleeding, etc.);
- •3. Has not corrected anticoagulation disorders;
- •4. Inability to provide informed consent;
- •5. Has any clinically significant condition that would, in the opinion of the
- •investigator, pre-clude study participation;
- •6. Unable or unwilling, in the opinion of the Investigator to comply with the
- •requirements of the protocol;
- •7. Employees of the investigator and study site or the sponsor, as well as
- •family members of the employees or the investigator or the sponsor;
- •8. Has inadequate bowel preparation, defined as: Boston Bowel Preparation Score
- •(BBPS) <6 or any segment <2 (each procedure report will include the BBPS);
- •9. Any woman who is pregnant or potentially pregnant.
研究者
相似试验
进行中（未招募）
1 期
Multicenter randomized two arms study evaluating the efficacy of prophylactic Rituximab in adult EBV negative kidney transplant recipients on incidence of EBV primary infection and post-transplant lymphoproliferative disordersKidney transplantationEpstein Barr virusEUCTR2020-000492-21-FRes Hôpitaux Universitaires de Strasbourg120
进行中（未招募）
1 期
Multicenter randomized two arms study evaluating the efficacy of prophylactic Rituximab in EBV negative kidney transplant recipients on incidence of EBV primary infection and post-transplant lymphoproliferative disorders -REPLYCTIS2024-515075-36-00es Hopitaux Universitaires De Strasbourg100
进行中（未招募）
1 期
Trial to assess if pain after surgery to remove their womb via the vagina is reduced using local anaesthetic in addition to the usual general anaesthetic.Pain suffered in the first 24 hours post vaginal hysterectomyMedDRA version: 17.0Level: LLTClassification code 10036236Term: Postoperative pain reliefSystem Organ Class: 100000004865MedDRA version: 17.0Level: LLTClassification code 10054711Term: Postoperative painSystem Organ Class: 100000004863EUCTR2013-004124-11-GBKing's College Hospital NHS Foundation Trust153
招募中
不适用
A multicenter, double arm clinical study to assess the safety & efficacy of CardioSAM ECGagainst the conventional 12 channel ECGCTRI/2021/03/032160Samtech Devices India Pvt Ltd
进行中（未招募）
2 期
Phase II Study of Bemcentinib for the Treatment of COVID-19 in Hospitalised PatientsCTRI/2020/10/028602BerGenBio ASA